论文部分内容阅读
高血压是慢性肾功能不全(CRI)最常见并发症之一,其处理对肾病患者的预后极为重要。心痛定是一种钙拮抗剂,近年报道治疗高血压和高血压危象有效,但迄今,有关本药在肾功能不全患者高血压中的使用尚极少或未见报告。该文报道心痛定两种剂型对两组尿毒症患者血压的急性效应,以及在原先治疗的基础上,加用慢释放剂对CRI伴持续性高血压患者的长期效果。病人和方法1.对血压的急性效应:开始用心痛定治疗前至少
Hypertension is one of the most common complications of chronic renal insufficiency (CRI), and its management is extremely important for the prognosis of patients with nephropathy. Heartachek is a calcium antagonist, reported in recent years, the treatment of hypertension and hypertension crisis effective, but so far, the drug in patients with renal insufficiency use of hypertension is still very little or no report. The article reports the acute effects of two forms of nifedipine on blood pressure in patients with uremia and the long-term effects of slow release agent on patients with CRI with persistent hypertension based on the previous treatment. Patients and Methods 1. Acute effects on blood pressure: Start with at least nifedipine before treatment